This is a record

Captured March 12, 2022 5:32 am

View Mode: Standard Screenshot
Title
Why We May Never Know Whether the $56,000-a-Year Alzheimer’s Drug Actually Works | Kaiser Health News
Description
It could take years for follow-up studies to prove Aduhelm slows the disease — or doesn’t. Meanwhile, its maker will profit.